LaurenElizabeth(Jesse)NyeMD

PubMed

• 8 citations
  ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
  Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home...> ;NPJ Breast Cancer. 2023 Mar 6
• Everolimus for Estrogen Receptor-negative Breast Cancer Prevention: A Journey Begun?
  Lauren Nye, Seema A Khan> ;Cancer Prevention Research. 2022 Dec 1
• 17 citations
  Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
  Rachel Yoder, Bruce F Kimler, Joshua M Staley, Kelsey Schwensen, Yen Y Wang, Karissa Finke, Anne O'Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Rob...> ;NPJ Breast Cancer. 2022 Jul 11
• 8 citations
  Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors
  Carol J. Fabian, Jennifer R. Klemp, Nicholas J. Marchello, Eric D. Vidoni, Debra K. Sullivan, Jennifer L. Nydegger, Teresa A. Phillips, Amy L. Kreutzjans, Bill Hendry,...> ;Cancers. 2021 Sep 28
• 26 citations
  Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer
  Priyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid A. Mayer, Harsh B. Pathak, Marc Hoffmann, Shane R. Stecklein, Manana Elia, Sharon Lewis, Jecinta Sc...> ;Clinical Cancer Research. 2021 Feb 18
• 43 citations
  Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...
  Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang, Rachel Yoder, Joshua M Staley, Lindsey Prochaska, Jamie L. Wagner, Amanda L. Amin, Kelsey E. Lar...> ;Clinical Cancer Research. 2021 Feb 15
• Integrating Breast Cancer Risk Management into Primary Care.
  Lauren Nye> ;American Family Physician. 2020 Mar 15
• 20 citations
  Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
  Carol J. Fabian, Lauren Nye, Kandy R. Powers, Jennifer L. Nydegger, Amy L. Kreutzjans, Teresa A. Phillips, Trina Metheny, Onalisa Winblad, Carola M. Zalles, Christy R....> ;Cancer Prevention Research. 2019 Aug 16
• 47 citations
  Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions
  Lyndsey J. Kilgore, S. Korentager, Amanda N. Hangge, Amanda L. Amin, Christa R. Balanoff, Kelsey E. Larson, Melissa Mitchell, John Chen, Emily Burgen, Qamar J. Khan, A...> ;Annals of Surgical Oncology. 2018 Jul 9
• 12 citations
  Breast cancer outcomes after diagnosis of hormone positive breast cancer and subsequent pregnancy in the tamoxifen era
  Lauren Nye, Alfred Rademaker, William J. Gradishar> ;Clinical Breast Cancer. 2017 Jul 1
• 19 citations
  A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
  Mark Agulnik, Ricardo Costa, Mohammed M. Milhem, Alfred Rademaker, B. C. Prunder, D. Daniels, B. T. Rhodes, Catherine Humphreys, Susan Abbinanti, Lauren Nye, Rasima Ce...> ;Annals of Oncology. 2017 Jan 1
• 26 citations
  Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
  Cesar A. Santa-Maria, Lauren Nye, Martin Mutonga, Sarika Jain, William J. Gradishar> ;Oncology. 2016 Feb 15
• 3 citations
  Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literature.
  Lauren Nye, Timothy Huyck, William J. Gradishar> ;Journal of the National Comprehensive Cancer Network. 2012 Feb 1
• Join now to see all